SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-098865
Filing Date
2022-04-07
Accepted
2022-04-07 16:06:11
Documents
12
Period of Report
2022-04-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d254319d8k.htm   iXBRL 8-K 25287
  Complete submission text file 0001193125-22-098865.txt   147095

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vir-20220404.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20220404_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20220404_pre.xml EX-101.PRE 11253
6 EXTRACTED XBRL INSTANCE DOCUMENT d254319d8k_htm.xml XML 3346
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 22813907
SIC: 2836 Biological Products, (No Diagnostic Substances)